GTechnology · Information Technology ServicesThe 12 Wall Street analysts covering Genpact Ltd. hold a median 12-month price target of $43 — +24.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 91 of 100 as at 8 Oct 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Genpact Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (98): The share price has been relatively steady.
Momentum (31): The shares have been drifting down relative to others.
Size (20): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on G, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +24.0% from it.
Of the 20 most recent actions, 4 moved their price target up and 3 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 7 Aug 2026 | Citigroup | Maintains | Neutral | $32 → $36 |
| 7 Aug 2026 | JP Morgan | Maintains | Neutral | $40 → $45 |
| 7 Aug 2026 | Needham | Maintains | Buy | $50 → $45 |
| 7 Aug 2026 | Susquehanna | Maintains | Neutral | $33 → $37 |
| 7 Aug 2026 | TD Cowen | Maintains | Buy | $42 → $43 |
| 9 July 2026 | TD Cowen | Maintains | Buy | — |
| 9 July 2026 | TD Cowen | Maintains | Buy | $47 → $42 |
| 7 July 2026 | Baird | Maintains | Neutral | — |
| 7 July 2026 | Baird | Maintains | Neutral | $45 → $38 |
| 11 May 2026 | Baird | Maintains | Neutral | — |
| 11 May 2026 | Citigroup | Maintains | Neutral | — |
| 11 May 2026 | Mizuho | Maintains | Neutral | — |
| 8 May 2026 | Needham | Reiterates | Buy | — |
| 5 May 2026 | Susquehanna | Maintains | Neutral | — |
| 10 Feb 2026 | Mizuho | Maintains | Neutral | — |
| 6 Feb 2026 | Needham | Maintains | Buy | — |
| 22 Oct 2025 | Citigroup | Initiates | Neutral | — |
| 20 Aug 2025 | JP Morgan | Maintains | Neutral | — |
| 8 Aug 2025 | Needham | Maintains | Buy | — |
| 17 July 2025 | Deutsche Bank | Reinstates | Hold | $47 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. G appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 8 Oct 2026, Genpact Ltd. returned −13.4% against +16.2% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 58% of US stocks
Cheaper than 67% of US stocks
Cheaper than 42% of US stocks
Cheaper than 47% of US stocks
Higher than 44% of US stocks
Higher than 48% of US stocks
Higher than 44% of US stocks
Higher than 72% of US stocks
Higher than 72% of US stocks
Higher than 83% of US stocks
Higher than 91% of US stocks
Higher than 80% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Genpact Ltd. has a market value of $5.6B and an enterprise value of $6.5B.
Revenue in the twelve months to 30 June 2026: $5.3B. The latest quarter grew 7.1% year on year.
Net income over the same four quarters: $582.7M, a 11.1% net margin.
Diluted earnings per share, trailing twelve months: $3.37.
Free cash flow in the twelve months to 30 June 2026: $548.7M.
Genpact Ltd. spent $310.1M on share buybacks and $121.7M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 9.9×; forward P/E: 7.4× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 2.26%, paying out 21% of earnings.
Genpact Ltd. employs 141,000 people — $37K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Genpact Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Genpact said it will report its third-quarter 2026 financial results after market close on November 5, 2026. Management will host a conference call at 5:00 p.m. following the release.
Why it matters — The announcement gives G watchers the date and time to follow the company's quarterly results and management discussion.
Zacks Investment Research cites Genpact's 13.6% stock rally, AI-led growth, rising earnings estimates and steady shareholder returns as reasons investors may consider the stock.
Why it matters — These cited factors highlight recent performance and growth and earnings trends that may interest investors following G.
Zacks Investment Research published a piece comparing Genpact (G) and Nutanix (NTNX) as value opportunities within the Computers - IT Services sector, asking which of the two stocks currently presents the better value for investors.
Why it matters — Genpact watchers would care because the comparison positions G among value considerations in its sector and invites scrutiny of its relative valuation.
Zacks Investment Research highlighted Genpact (G) as a strong value stock, citing its Zacks Style Scores feature that helps investors identify promising stocks based on value, growth, or momentum criteria.
Why it matters — A positive value-focused assessment from Zacks could draw attention from value investors tracking Genpact's stock.
Genpact shares rose 24.8% over the past three months. According to Zacks Investment Research, the stock's climb was supported by momentum in Agentic Operations, capital returns, and strong liquidity that have boosted investor confidence.
Why it matters — This price performance signals strengthening investor sentiment driven by Genpact's operations momentum and solid financial position, which a Genpact watcher would view as a favorable indicator for the company.
The 12 Wall Street analysts covering Genpact Ltd. have a median 12-month price target of $43, with estimates ranging from $31 to $58. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 12 analysts covering Genpact Ltd., 5 rate it a Buy, 7 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Genpact Ltd. 91 out of 100 across roughly 4,600 US stocks as at 8 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 8 Oct 2026, Genpact Ltd. ranks 91 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (98 of 100).
No one can know that. What the data says: the median 12-month target from 12 analysts implies +24.0% from the last close, and Ticker Nerd's factor model ranks Genpact Ltd. 91 out of 100 as at 8 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Genpact Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for G are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $31 to $58 over the next 12 months.
Genpact Ltd. returned -13.4% over the 12 months to 8 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Genpact Limited is a global professional services and technology company that helps enterprises transform and manage complex operations. Genpact Limited provides digital transformation, business process management, data and analytics, technology consulting, and artificial intelligence services to clients across industries including financial services, consumer and healthcare, and high tech and manufacturing.
The most recent item we track (PRNewsWire, 8 Oct 2026): "Genpact to Report Third Quarter 2026 Results". Genpact said it will report its third-quarter 2026 financial results after market close on November 5, 2026. Management will host a conference call at 5:00 p.m. following the release.
Genpact Limited is a global professional services and technology company that helps enterprises transform and manage complex operations. Genpact Limited provides digital transformation, business process management, data and analytics, technology consulting, and artificial intelligence services to clients across industries including financial services, consumer and healthcare, and high tech and manufacturing. Its offerings cover functions such as finance and accounting, procurement, supply chain, human resources, sales, and commercial operations, supporting organizations that rely on large-scale, data-driven workflows. The company serves businesses across India, the rest of Asia, North and Latin America, and Europe, positioning itself as an operations partner for multinational enterprises seeking process efficiency and technology-enabled execution. Founded in 1997 and headquartered in Hamilton, Bermuda, Genpact Limited remains focused on combining domain expertise with automation, analytics, and AI to support mission-critical business processes.
CEO Mr. Balkrishan Kalra · 141,000 employees · Bermuda · https://www.genpact.com
